NASDAQ:NDRA ENDRA Life Sciences (NDRA) Stock Price, News & Analysis → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free NDRA Stock Alerts $0.27 -0.01 (-3.51%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range$0.25▼$0.2950-Day Range$0.23▼$1.0652-Week Range$0.22▼$2.79Volume41,748 shsAverage Volume152,694 shsMarket Capitalization$3.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get ENDRA Life Sciences alerts: Email Address Ad Chaikin AnalyticsLog Into Marc's $5,000 System TodayNew Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. About ENDRA Life Sciences Stock (NASDAQ:NDRA)ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.Read More NDRA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NDRA Stock News HeadlinesMay 22, 2024 | uk.investing.comENDRA meets with FDA on liver device clinical trial designMay 21, 2024 | msn.comR.I. will issue $80m bond for URI life sciences building this year, Speaker Shekarchi saysMay 20, 2024 | businesswire.comENDRA Provides Update Following In-person Meeting with FDAMay 15, 2024 | msn.comScience is making anti-aging progress. But do we want to live forever?May 15, 2024 | msn.comENDRA Life Sciences Inc. (NASDAQ:NDRA) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comENDRA Life Sciences Inc (NDRA) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...May 14, 2024 | investorplace.comNDRA Stock Earnings: ENDRA Life Sciences Beats EPS for Q1 2024May 14, 2024 | businesswire.comENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business UpdateMay 14, 2024 | omaha.comExact Sciences blood test for many cancers is going to patients this summerMay 9, 2024 | morningstar.comENDRA Life Sciences Inc Registered ShsMay 7, 2024 | finance.yahoo.comENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024May 7, 2024 | bizjournals.comLife sciences firm picks Triangle over Boston, Philly for 170-job facilityMay 2, 2024 | finanznachrichten.deENDRA Life Sciences Inc.: ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International PatentsMay 2, 2024 | msn.comLife's insiders: Decoding endosymbiosis with mathematicsMay 2, 2024 | businesswire.comENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International PatentsApril 26, 2024 | reuters.comIndia's Glenmark Life Sciences posts lower Q4 profit as Red Sea crisis hurts API businessApril 12, 2024 | markets.businessinsider.comIRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in ColumbusApril 1, 2024 | finance.yahoo.comENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | finance.yahoo.comQ4 2023 ENDRA Life Sciences Inc Earnings CallMarch 28, 2024 | businesswire.comENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 27, 2024 | benzinga.comEarnings Preview For ENDRA Life SciencesMarch 21, 2024 | finance.yahoo.comENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024March 14, 2024 | msn.comNuclera appoints Joseph Bertelsen as Chief Commercial OfficerMarch 6, 2024 | bizjournals.comLife sciences companies need more than just scientistsFebruary 28, 2024 | msn.comENDRA installs first TAEUS liver system at London hospitalSee More Headlines Receive NDRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today5/28/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:NDRA CUSIPN/A CIK1681682 Webwww.endrainc.com Phone(734) 335-0468FaxN/AEmployees21Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,060,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-204.78% Return on Assets-153.48% Debt Debt-to-Equity RatioN/A Current Ratio1.04 Quick Ratio1.04 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.67 per share Price / Book0.43Miscellaneous Outstanding Shares11,040,000Free Float10,506,000Market Cap$3.17 million OptionableNot Optionable Beta1.13 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Francois Michelon (Age 58)Chairman, President & CEO Comp: $388.45kMs. Irina Pestrikova (Age 37)Senior Director of Finance & Secretary Comp: $185kMr. Michael Thornton Ph.D. (Age 56)Chief Technology Officer Comp: $279.24kDr. Jonathan Behr Ph.D.Co-FounderMr. Steve FreemanHuman Resources LeaderKey CompetitorsHelius Medical TechnologiesNASDAQ:HSDTNuwellisNASDAQ:NUWEZyVersa TherapeuticsNASDAQ:ZVSACyclacel PharmaceuticalsNASDAQ:CYCC60 Degrees PharmaceuticalsNASDAQ:SXTPView All Competitors NDRA Stock Analysis - Frequently Asked Questions How have NDRA shares performed in 2024? ENDRA Life Sciences' stock was trading at $2.12 on January 1st, 2024. Since then, NDRA shares have decreased by 87.0% and is now trading at $0.2748. View the best growth stocks for 2024 here. Are investors shorting ENDRA Life Sciences? ENDRA Life Sciences saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 104,700 shares, an increase of 2,517.5% from the April 30th total of 4,000 shares. Based on an average daily volume of 184,100 shares, the days-to-cover ratio is presently 0.6 days. Currently, 1.0% of the company's stock are short sold. View ENDRA Life Sciences' Short Interest. When is ENDRA Life Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our NDRA earnings forecast. How were ENDRA Life Sciences' earnings last quarter? ENDRA Life Sciences Inc. (NASDAQ:NDRA) issued its quarterly earnings results on Thursday, March, 28th. The company reported ($0.17) earnings per share (EPS) for the quarter. What other stocks do shareholders of ENDRA Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other ENDRA Life Sciences investors own include Advanced Micro Devices (AMD), Trevena (TRVN), VBI Vaccines (VBIV), Bionano Genomics (BNGO), OPKO Health (OPK), TherapeuticsMD (TXMD), electroCore (ECOR) and Genocea Biosciences (GNCA). When did ENDRA Life Sciences IPO? ENDRA Life Sciences (NDRA) raised $10 million in an initial public offering (IPO) on Friday, February 3rd 2017. The company issued 2,000,000 shares at a price of $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO. How do I buy shares of ENDRA Life Sciences? Shares of NDRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NDRA) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBitcoin’s Biggest Year YetParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
